CDXS Live signals | Maximize Profits with Getagraph.com

SELL 102906 min ago

@ $2.88

Issued: 14 Feb 2024 @ 09:31

Return: -7.96%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: 0.67 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	265 046
Average Volume	574 582
Market Cap	186.30M
EPS	$0 ( 2024-02-28 )
Next earnings date	( $-0.170 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.37
ATR14	$0.00500 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-01	Ryali Sriram	Buy	314 125	Stock Option (Right to Buy)
2024-01-01	Ryali Sriram	Buy	52 350	Common Stock
2024-01-01	Norrett Kevin	Buy	314 125	Stock Option (Right to Buy)
2024-01-01	Norrett Kevin	Buy	52 350	Common Stock
2024-01-01	Fitzgerald Margaret Nell	Buy	314 125	Stock Option (Right to Buy)

INSIDER POWER
79.04
Last 93 transactions
Buy: 6 649 590 \| Sell: 1 047 461

Volume Correlation

Long: -0.13 (neutral)

Short: -1.00 (very strong negative)

Signal:(34.196) Neutral

Codexis Inc Correlation

10 Most Positive Correlations
ZD	0.978
SRTS	0.967
LGHL	0.958
NWL	0.954
NMTR	0.952
TBNK	0.952
GDS	0.95
MODV	0.949
WMG	0.949
TRIP	0.948

10 Most Negative Correlations
MTRY	-0.947
AHRN	-0.943
AFAR	-0.94
FRSG	-0.939
MCAA	-0.938
TBSA	-0.934
LEGA	-0.933
CITE	-0.932
NBSTU	-0.931
MSDA	-0.931

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Codexis Inc Correlation - Currency/Commodity

0.51
( weak )

0.39
( neutral )

0.00
( neutral )

0.46
( neutral )

0.13
( neutral )

-0.27
( neutral )

Codexis Inc Financials

Annual	2023
Revenue:	$70.14M
Gross Profit:	$51.82M (73.87 %)
EPS:	$-1.120

Q4	2023
Revenue:	$26.56M
Gross Profit:	$22.48M (84.65 %)
EPS:	$-0.100

Q3	2023
Revenue:	$9.28M
Gross Profit:	$7.03M (75.76 %)
EPS:	$-0.500

Q2	2023
Revenue:	$21.32M
Gross Profit:	$18.15M (85.10 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.